Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) regularly issues detailed news releases about its work in recombinant spider silk and bioengineered fibers. The company describes itself as a world leader in spider silk technology and uses its news flow to report on production milestones, facility expansions, scientific progress, and commercial engagements.
News items often highlight advances in the company’s BAM-1 and BAM-1 Alpha hybrid silkworm lines, including selective breeding achievements that increase cocoon shell weight, throughput, and production efficiency. Kraig Biocraft Laboratories also reports on the launch and completion of spider silk production cycles, the deployment of BAM-1 Alpha as its primary production hybrid, and the integration of diapause egg management into its rearing operations.
Another recurring theme in KBLB news is the build-out of production infrastructure in Southeast Asia. Releases cover topics such as taking possession of additional silkworm rearing centers, relocating facilities to protected highlands, and maintaining multiple, parallel production sites to support scalability and resilience. The company also reports on securing usage rights to government-owned mulberry gardens and taking control of mulberry fields dedicated to its operations, emphasizing feedstock security and vertical coordination.
Investors and observers can also find updates on commercial and research developments, including pilot programs with a globally recognized performance sports apparel brand and announcements about scientific leadership and breakthroughs in advanced fibers and bioengineered materials. Together, these news items provide an ongoing view into Kraig Biocraft Laboratories’ efforts to expand spider silk production capacity, refine its technology, and pursue high-value applications in performance textiles, technical apparel, and other markets.
Kraig Biocraft Laboratories (OTCQB: KBLB) commissioned a new recombinant spider silk production rearing center, now operating as part of its April/May 2026 production cycle. The facility was deployed in under 30 days within an aggressive scale-up program.
Kraig Biocraft uses standardized facility designs and a multi-center strategy to expand capacity, improve efficiency, and add operational resiliency as it advances toward commercial-scale spider silk production. The company plans continued 2026 capacity additions and was featured on the March 2026 cover of National Geographic.
Kraig Biocraft Laboratories (OTCQB: KBLB) positions itself as an emerging leader in commercializing spider silk through validated science and advancing production capability. The company highlights peer-reviewed work on its transgenic silkworm platform, iterative R&D in strain and yield optimization, and ongoing production initiatives aimed at scaling toward commercial supply.
The release frames Kraig's approach as aligning with existing sericulture infrastructure to address cost and scalability limits faced by alternative synthetic routes, focusing investor attention on who can deliver consistent, scalable spider silk at viable cost.
Kraig Biocraft Laboratories (OTCQB: KBLB) launched its April/May production cycle after a record run that produced nearly 1.8 metric tons of recombinant spider silk cocoons. The company says the new cycle aims for a substantial increase as it scales toward a long-term goal of >10 metric tons in a single month and is evaluating additional facility expansions in Southeast Asia to support capacity and downstream processing.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced on April 30, 2026 that a recent production run yielded approximately 1.8 metric tons of recombinant spider silk and that downstream processing and reeling of that batch succeeded.
The company says this dual milestone demonstrates scaled output and usable fiber conversion, advancing its path from development toward revenue-generating commercialization across textiles, defense, and technical fabrics.
Kraig Biocraft Laboratories (OTCQB: KBLB) reported progress converting its record 1.8 metric tons of recombinant spider silk cocoons into reeled silk, with conversion approximately 50% complete as of April 28, 2026. The company says finished fiber will create substantial inventory to support product development and commercial opportunities.
The company highlighted its March 2026 National Geographic cover and provided links for investor updates and images of reeled silk produced to date.
Kraig Biocraft Laboratories (OTCQB: KBLB) began processing nearly 1.8 metric tons of recombinant spider silk cocoons into finished reeled silk, a production record after exceeding 1.3 metric tons in March.
The reeling is underway with a production partner and is expected to finish by month-end, creating the company's largest-ever inventory for luxury, performance textile, and industrial uses.
Summary not available.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced senior management is traveling to South East Asia following a record monthly production of 1.3 metric tons of recombinant spider silk cocoons on April 13, 2026. The trip will review production quality, oversee downstream reeled-silk processing, and coordinate expansion with Prodigy Silk and the production network.
The company reiterated its near-term roadmap to scale toward a 10 metric ton monthly production target and highlighted leadership coverage in National Geographic.
Kraig Biocraft Laboratories (OTCQB: KBLB) reported deploying 700,000 BAM-1 Alpha production hybrids and producing >1.3 metric tons of recombinant spider silk cocoons in a single month (April 2026), a fivefold record increase. Management targets a near-term goal of 10 metric tons per month, moving from research to industrial-scale production.
The milestone validates the company’s vertically integrated platform—from genetic design to cocoon production—and signals potential commercial applications across textiles, aerospace, medical devices, and sustainable materials, while noting scaling, infrastructure, and demand-development challenges.
Kraig Biocraft Laboratories (OTCQB: KBLB) produced over 1.3 metric tons of recombinant spider silk cocoons in a single month on April 6, 2026, a fivefold increase over its prior record. The company says this validates its scale-up strategy and advances its plan to reach 10 metric tons per month within coming months.
Expanded facilities, new BAM-1 Alpha production hybrids, and vertically integrated operations reportedly enabled the ramp without operational disruptions.